Clinical Trials Browser

Breast Neoplasms, Neoplasm Recurrence, Local

NCT07198945 2026-05-14

STARLING

Phase NA Not yet recruiting

546 enrolled

Gastrointestinal

Adenoma, Colonic Neoplasms, Colonic Polyps, Neoplasm Recurrence, Local, Recurrence

NCT06532539 2026-04-24

Cadonilimab With Chemoradiation for Recurrent and Oligometastatic Endometrial Carcinoma

Phase 2 Recruiting

30 enrolled

Gynecologic

Neoplasm Metastasis, Neoplasm Recurrence, Local, Neoplasms, Endometrial Neoplasms

NCT07100730 2026-04-16

IPAX BrIGHT

Phase 3 Recruiting

50 enrolled

CNS

Brain Neoplasms, Glioblastoma, Neoplasm Recurrence, Local, Neoplasms, Central Nervous System Neoplasms

NCT07483658 2026-03-19

HYP-OP-RT

Phase NA Not yet recruiting

434 enrolled

GastrointestinalGenitourinary

Gastrointestinal Diseases, Neoplasm Recurrence, Local, Prostatic Neoplasms, Radiation Injuries, Urologic Diseases

NCT07398170 2026-02-09

BIOLIMEN-1

Phase NA Not yet recruiting

15 enrolled

CNS

Meningioma, Neoplastic Cells, Circulating, Neoplasm Recurrence, Local

NCT03583619 2026-01-26

Randomized Trial of Accelerated Partial Breast Irradiation

Phase NA Completed

140 enrolled

Breast

Breast Neoplasms, Neoplasm Recurrence, Local

NCT06912087 2025-12-02

Dose Finding Study of Zanzalintinib With Pembrolizumab and Cetuximab in Head and Neck SCC

Phase 1 Recruiting

36 enrolled

Head & Neck

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Neoplasm Metastasis, Neoplasm Recurrence, Local

Clinical Trials

Accelerated Partial Breast Irradiation With IMRT in Early Breast Cancer

STARLING

Cadonilimab With Chemoradiation for Recurrent and Oligometastatic Endometrial Carcinoma

IPAX BrIGHT

HYP-OP-RT

BIOLIMEN-1

Randomized Trial of Accelerated Partial Breast Irradiation

Dose Finding Study of Zanzalintinib With Pembrolizumab and Cetuximab in Head and Neck SCC